EVOLENT HEALTH INC - A (EVH) Stock Earnings Estimates
USA • New York Stock Exchange • NYSE:EVH • US30050B1017
2.89 USD
-0.17 (-5.56%)
At close: Feb 5, 2026
2.89 USD
0 (0%)
After Hours: 2/5/2026, 8:22:36 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.352B 48.90% | 1.964B 45.26% | 2.555B 30.09% | 1.894B -25.86% | 2.403B 26.87% | 2.717B 13.07% | 3.149B 15.90% | 3.564B 13.18% | 4.148B 16.39% | 4.613B 11.21% | |
| EBITDA YoY % growth | 70.8M 301.36% | 136.212M 92.39% | 115.795M -14.99% | 150.88M 30.30% | 156.61M 3.80% | 189.3M 20.87% | 235.42M 24.36% | 270.95M 15.09% | 287.04M 5.94% | 323.81M 12.81% | |
| EBIT YoY % growth | 3.6M 108.49% | 12.797M 255.47% | -2.575M -120.12% | 95.451M 3,806.83% | 98.415M 3.11% | 122.21M 24.18% | 210.84M 72.52% | 253.28M 20.13% | 538.43M 112.58% | N/A | |
| Operating Margin | 0.27% | 0.65% | -0.10% | 5.04% | 4.10% | 4.50% | 6.70% | 7.11% | 12.98% | N/A | |
| EPS YoY % growth | 0.91 4,450.00% | 0.88 -3.30% | 0.66 -25.00% | 0.07 -88.92% | 0.35 380.41% | 0.53 50.78% | 0.76 43.03% | 0.97 28.00% | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.06 391.64% | 0.07 11.10% | 0.07 174.74% | 0.10 97.15% | 0.10 68.83% | 0.09 36.36% | 0.11 53.15% | 0.13 33.20% | 0.15 53.85% |
| Revenue Q2Q % growth | 473.39M -26.78% | 556.27M 15.02% | 595.34M 33.99% | 623.27M 29.97% | 630.26M 33.14% | 642.78M 15.55% | 647.22M 8.71% | 659.55M 5.82% | 664.92M 5.50% |
| EBITDA Q2Q % growth | 36.546M -72.44% | 36.52M 40.24% | 39.354M -15.96% | 41.671M -42.58% | 42.51M 16.32% | 43.544M 19.23% | 46.054M 17.02% | 47.335M 13.59% | 49.286M 15.94% |
| EBIT Q2Q % growth | 22.76M 60.12% | 25.044M 1,162.30% | 26.688M 7,293.53% | 27.864M 1,486.79% | 27.713M 21.76% | 31.074M 24.08% | 35.796M 34.13% | 36.179M 29.84% | 38.872M 40.27% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.05 25.00% | 0.11 | -0.06 | -52.63% |
| Q2 2025 Q2Q % growth | -0.10 -133.33% | 0.08 | -0.18 | -226.45% |
| Q1 2025 Q2Q % growth | 0.06 -82.35% | 0.10 | -0.04 | -37.77% |
| Q4 2024 Q2Q % growth | -0.02 -108.70% | 0.01 | -0.03 | -332.96% |
| Q3 2024 Q2Q % growth | 0.04 -86.67% | 0.34 | -0.30 | -88.41% |
| Q2 2024 Q2Q % growth | 0.30 114.29% | 0.26 | 0.04 | 17.44% |
| Q1 2024 Q2Q % growth | 0.34 61.90% | 0.24 | 0.10 | 39.63% |
| Q4 2023 Q2Q % growth | 0.23 130.00% | 0.15 | 0.08 | 52.95% |
| Q3 2023 Q2Q % growth | 0.30 -49.15% | 0.07 | 0.23 | 333.18% |
| Q2 2023 Q2Q % growth | 0.14 40.00% | 0.11 | 0.03 | 22.82% |
| Q1 2023 Q2Q % growth | 0.21 75.00% | 0.20 | 0.01 | 2.68% |
| Q4 2022 Q2Q % growth | 0.10 25.00% | 0.17 | -0.07 | -39.73% |
| Q3 2022 Q2Q % growth | 0.59 2,066.67% | 0.12 | 0.47 | 392.67% |
| Q2 2022 Q2Q % growth | 0.10 600.00% | 0.05 | 0.05 | 103.85% |
| Q1 2022 Q2Q % growth | 0.12 1,300.00% | 0.00 | 0.12 | 6,040.59% |
| Q4 2021 Q2Q % growth | 0.08 900.00% | 0.01 | 0.07 | 850.88% |
| Q3 2021 Q2Q % growth | -0.03 | -0.03 | 0.00 | 9.61% |
| Q2 2021 Q2Q % growth | -0.02 33.33% | -0.04 | 0.02 | 44.99% |
| Q1 2021 Q2Q % growth | -0.01 92.86% | -0.07 | 0.06 | 84.77% |
| Q4 2020 Q2Q % growth | -0.01 | -0.05 | 0.04 | 78.59% |
| Q3 2020 Q2Q % growth | -0.03 | -0.04 | 0.01 | 32.49% |
| Q2 2020 Q2Q % growth | -0.03 | -0.10 | 0.07 | 70.02% |
| Q1 2020 Q2Q % growth | -0.14 | -0.13 | -0.01 | -5.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 479.533M -22.83% | 472.17M | 7.363M | 1.56% |
| Q2 2025 Q2Q % growth | 444.328M -31.34% | 464.02M | -19.692M | -4.24% |
| Q1 2025 Q2Q % growth | 483.649M -24.39% | 464.91M | 18.739M | 4.03% |
| Q4 2024 Q2Q % growth | 646.542M 16.27% | 657.7M | -11.158M | -1.70% |
| Q3 2024 Q2Q % growth | 621.401M 21.60% | 633.42M | -12.019M | -1.90% |
| Q2 2024 Q2Q % growth | 647.145M 37.94% | 642.8M | 4.345M | 0.68% |
| Q1 2024 Q2Q % growth | 639.653M 49.56% | 606.83M | 32.823M | 5.41% |
| Q4 2023 Q2Q % growth | 556.055M 45.41% | 547.82M | 8.235M | 1.50% |
| Q3 2023 Q2Q % growth | 511.015M 44.93% | 514.33M | -3.315M | -0.64% |
| Q2 2023 Q2Q % growth | 469.136M 46.65% | 465.31M | 3.826M | 0.82% |
| Q1 2023 Q2Q % growth | 427.69M 43.95% | 438.68M | -10.99M | -2.51% |
| Q4 2022 Q2Q % growth | 382.4M 53.95% | 376.66M | 5.74M | 1.52% |
| Q3 2022 Q2Q % growth | 352.6M 58.47% | 360.34M | -7.74M | -2.15% |
| Q2 2022 Q2Q % growth | 319.9M 44.03% | 300.82M | 19.08M | 6.34% |
| Q1 2022 Q2Q % growth | 297.1M 38.12% | 289.64M | 7.46M | 2.58% |
| Q4 2021 Q2Q % growth | 248.4M 0.77% | 236.22M | 12.18M | 5.16% |
| Q3 2021 Q2Q % growth | 222.5M -7.14% | 227.88M | -5.38M | -2.36% |
| Q2 2021 Q2Q % growth | 222.1M 2.21% | 219.09M | 3.01M | 1.37% |
| Q1 2021 Q2Q % growth | 215.1M -2.76% | 214.92M | 180K | 0.08% |
| Q4 2020 Q2Q % growth | 246.5M | 264.17M | -17.67M | -6.69% |
| Q3 2020 Q2Q % growth | 239.6M | 266.41M | -26.81M | -10.06% |
| Q2 2020 Q2Q % growth | 217.3M | 243.44M | -26.14M | -10.74% |
| Q1 2020 Q2Q % growth | 221.2M | 241.5M | -20.3M | -8.41% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.82% | -56.65% | -0.73% | -69.7% |
| Revenue | -0.21% | -2.64% | -0.05% | -0.42% |